ME Therapeutics Holdings Inc. announced a non-brokered private placement of up to 1,550,000 units at a price of CAD 1 per unit for gross proceeds of up to CAD 1,550,000 on February 27, 2024. Each unit will be comprised of one common share and one share purchase warrant. Each warrant will entitle the holder thereof to purchase one additional share at a price of CAD 1.50 per share for a period of two years from closing of the offering, subject to an acceleration provision whereby the expiry date of the warrants may be accelerated if the daily trading price of the shares equals or exceeds CAD 2 on the Exchange for a period of ten consecutive trading days in which event the company may in its discretion accelerate the expiry date of the warrants by giving notice via news release and, in such case, the warrants will expire on the 30th day after the date on which the news release is disseminated.

All securities issued in connection with the offering will be subject to a statutory hold period expiring four months and one day after closing of the offering. No finder?s fees are expected to be paid in connection with the offering. The completion of the offering remains subject to certain conditions, including confirmation of no objection from the Exchange.